Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 11/13/2019. Please visit our Tracking Ole Andreas Halvorsen...
SHANGHAI , Dec. 11, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today opened an innovation and customer support center i...
RADNOR, Pa. , Nov. 25, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield , President...
2019 has been a banner year for IPOs. Or rather it has been a banner year for the valuations of companies that have hit the public market for the first time. The five largest offerings of the year alone brought well over $100 billion to the stock market...but that value hasn't exactly stu...
Agilent (NYSE: A ) initiated with Hold rating and $85 (11% upside) price target at Stifel. More news on: Agilent Technologies, Inc., Avantor, Inc., Bio-Techne Corporation, Healthcare stocks news, Stocks on the move, , Read more ...
After a busy week in the IPO market, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio (ETNB) plans to raise $85 million at a $225 million market cap. The company's target indication represents a multi-billion-dollar market with no FDA-approved therapy; consequ...
Avantor, Inc. (NYSE:AVTR) Q3 2019 Earnings Conference Call November 5, 2019 8:30 AM ET Company Participants Helen O'Donnell - Investor Relations Michael Stubblefield - President and Chief Executive Officer Tom Szlosek - Executive Vice President and Chief Financial Officer Conf...
Avantor's in-line dilution systems to be installed at NIBRT's prestigious bioprocessing research and training facility in Dublin , adding to their full complement of technology Supports growing demand for improved buffer management in the biopharma manufacturing process RADNOR, Pennsyl...
Image source: The Motley Fool. AVANTOR (NYSE: AVTR) Q3 2019 Earnings Call Nov 5, 2019 , 8:30 a.m. ET Operator Continue reading
The following slide deck was published by Avantor, Inc. in conjunction with their 2019 Q3 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...